In fact, a previous report showed that the treatment of an ALS mice model with β-Lactam antibiotics increased the expression and activity of GLT-1, attenuated motor defects, and further increased the survival of these mice [229]. The gene discussed is SLC1A2; the disease is amyotrophic lateral sclerosis.